showed a trendP = .1
Several previously documented risk factors showed a trend for an association with VOD rate in the younger cohort including a hematopoietic cell transplantation–specific comorbidity index score of >3 (23% vs 12%; P = .1), myeloablative TBI compared with no myeloablative TBI (26% vs 15%; P = .2), and patients with ALL and exposure to InO compared with those with ALL not receiving InO (33 vs 21, P = .1).